DK1485084T3 - Anvendelse af et L-ascorbinsyresalt til at fremstille et farmaceutisk præparat til oftalmisk topisk anvendelse, der er i stand til at forbedre niveauet af L-ascorbinsyre i öjet - Google Patents

Anvendelse af et L-ascorbinsyresalt til at fremstille et farmaceutisk præparat til oftalmisk topisk anvendelse, der er i stand til at forbedre niveauet af L-ascorbinsyre i öjet

Info

Publication number
DK1485084T3
DK1485084T3 DK03744341T DK03744341T DK1485084T3 DK 1485084 T3 DK1485084 T3 DK 1485084T3 DK 03744341 T DK03744341 T DK 03744341T DK 03744341 T DK03744341 T DK 03744341T DK 1485084 T3 DK1485084 T3 DK 1485084T3
Authority
DK
Denmark
Prior art keywords
ascorbic acid
eye
prepare
improving
level
Prior art date
Application number
DK03744341T
Other languages
Danish (da)
English (en)
Inventor
Lucia Durando
Michele Virno
Mario Pinza
Leonardo Marchitto
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK1485084T3 publication Critical patent/DK1485084T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03744341T 2002-03-15 2003-03-05 Anvendelse af et L-ascorbinsyresalt til at fremstille et farmaceutisk præparat til oftalmisk topisk anvendelse, der er i stand til at forbedre niveauet af L-ascorbinsyre i öjet DK1485084T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000557A ITMI20020557A1 (it) 2002-03-15 2002-03-15 Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d

Publications (1)

Publication Number Publication Date
DK1485084T3 true DK1485084T3 (da) 2006-07-31

Family

ID=11449521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03744341T DK1485084T3 (da) 2002-03-15 2003-03-05 Anvendelse af et L-ascorbinsyresalt til at fremstille et farmaceutisk præparat til oftalmisk topisk anvendelse, der er i stand til at forbedre niveauet af L-ascorbinsyre i öjet

Country Status (12)

Country Link
US (1) US20060004089A1 (fr)
EP (1) EP1485084B9 (fr)
AR (1) AR039604A1 (fr)
AT (1) ATE322262T1 (fr)
AU (1) AU2003210419A1 (fr)
CA (1) CA2476908A1 (fr)
DE (1) DE60304458T2 (fr)
DK (1) DK1485084T3 (fr)
ES (1) ES2260634T3 (fr)
IT (1) ITMI20020557A1 (fr)
PT (1) PT1485084E (fr)
WO (1) WO2003077905A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008002582A2 (fr) * 2006-06-27 2008-01-03 Riolan Technologies, Inc. Compositions ophtalmiques absorbant les ultraviolets
US10220012B2 (en) * 2016-06-03 2019-03-05 Joerg H. KRUMEICH Solution for ophthalmology
US20210128526A1 (en) * 2019-11-05 2021-05-06 Rajiv R. Mohan Eye drops to treat chemically induced corneal damage

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490389A (en) * 1976-03-11 1984-12-25 Nelson Research & Development Co. Contact lens preserving solution containing ascorbic acid or salts thereof
JPS5821614A (ja) * 1981-07-31 1983-02-08 Ss Pharmaceut Co Ltd 点眼剤
DE3133003A1 (de) * 1981-08-20 1983-03-10 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Mittel zur behandlung von truebungen im bereich des auges
US4886815A (en) * 1984-06-20 1989-12-12 Schachar Ronald A Treatment and prevention of retinal edema with dopaminergic antagonists
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5523316A (en) * 1994-06-23 1996-06-04 Alcon Laboratories, Inc. Intraocular irrigating solution containing agent for controlling IOP
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
US5817630A (en) * 1997-03-18 1998-10-06 Austin Nutriceutical Corporation Glutathione antioxidant eye drops
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
WO2002001954A1 (fr) * 2000-07-05 2002-01-10 The Board Of Trustees Of The University Of Arkansas Utilisation d'acide ascorbique et de sels d'acide ascorbique pour ameliorer la reparation et la regeneration cellulaires post-lesionnelles

Also Published As

Publication number Publication date
DE60304458D1 (de) 2006-05-18
WO2003077905A1 (fr) 2003-09-25
ES2260634T3 (es) 2006-11-01
AR039604A1 (es) 2005-03-02
EP1485084B1 (fr) 2006-04-05
PT1485084E (pt) 2006-08-31
DE60304458T2 (de) 2006-10-12
EP1485084B9 (fr) 2006-08-23
ITMI20020557A0 (it) 2002-03-15
CA2476908A1 (fr) 2003-09-25
EP1485084A1 (fr) 2004-12-15
ITMI20020557A1 (it) 2003-09-15
AU2003210419A1 (en) 2003-09-29
US20060004089A1 (en) 2006-01-05
ATE322262T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
EA201100969A1 (ru) Солевые формы органического соединения
LTC1793824I2 (lt) Naujos farmacinės kompozicijos, apimančios 4-(4-(3-(4-chlor-3-trifluormetilfenil)ureido)-3-fluorfenoksi)piridin-2-karboksirūgštį, hiperproliferacinių sutrikimų gydymui
CR9587A (es) Derivados de piridazina
CY2013023I1 (el) Φαρμακο για την υπερδραστηρια ουροδοχο κυστη περιλαμβανον παραγωγο ανιλιδιου οξικου οξεος ως το ενεργο συστατικο
GT200500034A (es) Inhibidores de la proteina tirosina fosfatasa 1b
ATE517874T1 (de) Pyrimidinone als modulatoren von caseinkinase ii (ck2)
NO20091548L (no) Imidazolon- og imidazolidinonderivater som 11B-HSD1 inhibitorer for diabetes
WO2012015810A3 (fr) Compositions pharmaceutiques contenant du pemetrexed présentant une stabilité en stockage prolongé
TW200626558A (en) Indazolone derivatives
EA200801083A1 (ru) Новые производные дигидропсевдоэритромицина
NO20076648L (no) Novel thiophene derivatives
CR7718A (es) Nuevos derivados de glicosido de tiofeno, metodos para la preparacion de los mismos, medicamentos que comprenden dichos compuestos, y su uso
NO20091395L (no) Nye tiofenderivater
NO20071658L (no) Alkil-pyridiner som 11-beta-inhibitorer for diabetes
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
WO2006000371A3 (fr) Derives de pyrimidine
DK2116227T3 (da) Ophthalmiske sammensætninger, indeholdende en synergistisk kombination af to polymerer
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
ECSP088229A (es) Derivados de pirazolona como inhibidores de 11-beta hsd1
WO2004091630A8 (fr) Remedes a des affections, a usage ophtalmique
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
NO20042158L (no) Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme
DE602004011548D1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
BRPI0515529A (pt) inseticidas